Raymond James Financial Services Advisors’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,578
Closed -$222K 3406
2023
Q3
$222K Sell
5,578
-17
-0.3% -$676 ﹤0.01% 2860
2023
Q2
$229K Sell
5,595
-200
-3% -$8.2K ﹤0.01% 2829
2023
Q1
$238K Buy
5,795
+181
+3% +$7.42K ﹤0.01% 2782
2022
Q4
$230K Sell
5,614
-331,400
-98% -$13.6M ﹤0.01% 2768
2022
Q3
$13.5M Buy
337,014
+331,254
+5,751% +$13.3M 0.03% 511
2022
Q2
$242K Sell
5,760
-811
-12% -$34.1K ﹤0.01% 2743
2022
Q1
$298K Buy
6,571
+238
+4% +$10.8K ﹤0.01% 2715
2021
Q4
$292K Buy
6,333
+284
+5% +$13.1K ﹤0.01% 2725
2021
Q3
$287K Buy
6,049
+391
+7% +$18.6K ﹤0.01% 2715
2021
Q2
$293K Buy
5,658
+74
+1% +$3.83K ﹤0.01% 2739
2021
Q1
$281K Sell
5,584
-485
-8% -$24.4K ﹤0.01% 2666
2020
Q4
$316K Buy
6,069
+1,261
+26% +$65.7K ﹤0.01% 2430
2020
Q3
$209K Buy
+4,808
New +$209K ﹤0.01% 2510
2018
Q4
Sell
-4,302
Closed -$209K 2818
2018
Q3
$209K Buy
+4,302
New +$209K ﹤0.01% 2501
2018
Q2
Sell
-5,665
Closed -$237K 2812
2018
Q1
$237K Sell
5,665
-221
-4% -$9.25K ﹤0.01% 2154
2017
Q4
$256K Sell
5,886
-7,211
-55% -$314K ﹤0.01% 2102
2017
Q3
$557K Sell
13,097
-1,317
-9% -$56K ﹤0.01% 1652
2017
Q2
$620K Buy
14,414
+43
+0.3% +$1.85K ﹤0.01% 1558
2017
Q1
$601K Sell
14,371
-49
-0.3% -$2.05K ﹤0.01% 1470
2016
Q4
$564K Sell
14,420
-22,168
-61% -$867K ﹤0.01% 1464
2016
Q3
$1.62M Sell
36,588
-1,369
-4% -$60.5K 0.01% 853
2016
Q2
$1.59M Sell
37,957
-3,365
-8% -$141K 0.02% 840
2016
Q1
$1.66M Sell
41,322
-1,592
-4% -$64.1K 0.02% 698
2015
Q4
$2.2M Buy
42,914
+3,555
+9% +$182K 0.03% 611
2015
Q3
$1.85M Buy
39,359
+13,743
+54% +$645K 0.03% 551
2015
Q2
$1.6M Buy
+25,616
New +$1.6M 0.11% 237
2013
Q3
Sell
-34,190
Closed -$1.21M 961
2013
Q2
$1.21M Buy
+34,190
New +$1.21M 0.04% 552